TP53 and colorectal carcinoma: The present study aimed to investigate a possible prognostic role of IDO1 and Kyn and Trp metabolites in clinical CRC tumors and analyze the correlations between expression level IDO1 and mutation status of APC, TP53, and KRAS genes of CRC tissues.